Executives and directors at Pfizer, Moderna and other companies developing Covid-19 vaccines sold approximately $496 million of stock last year, reaping the rewards of positive vaccine developments on.wsj.com
@WSJ4 years ago
Executives and directors at Pfizer, Moderna and other companies developing Covid-19 vaccines sold approximately $496 million of stock last year, reaping the rewards of positive vaccine developments on.wsj.com
